MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM NEW
Total 13F shares
13,559,107
Share change
+6,500,229
Total reported value
$81,616,323
Put/Call ratio
0%
Price per share
$6.02
Number of holders
62
Value change
+$38,988,501
Number of buys
36
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q4 2015

As of 31 Dec 2015, MEDGENICS INC - COM NEW (MDGN) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,559,107 shares. The largest 10 holders included Broadfin Capital, LLC, JENNISON ASSOCIATES LLC, Opaleye Management Inc., ADAGE CAPITAL PARTNERS GP LLC, QVT Financial LP, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A.. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.